Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 410-610-2 | CAS number: 111850-24-9 MORTRACE SB CONC.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was carried out according to OECD Guideline No. 402 and EEC Directive 84/449/EEC, Part B.3 and in accordance with the Principles of Good Laboratory Practices (GLP).
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Remarks:
- Concentration, stability and homogeneity of test substance in vehicle were not determined by analytical procedures
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Remarks:
- same as above
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- MORTRACE SB CONC.
- IUPAC Name:
- MORTRACE SB CONC.
- Reference substance name:
- 4-(4-Nitrophenylazo)-2,6-di- sec.butylphenol
- IUPAC Name:
- 4-(4-Nitrophenylazo)-2,6-di- sec.butylphenol
- Reference substance name:
- 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol
- EC Number:
- 410-610-2
- EC Name:
- 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol
- Cas Number:
- 111850-24-9
- Molecular formula:
- C20 H25 N3 O3
- IUPAC Name:
- 2,6-bis(butan-2-yl)-4-[2-(4-nitrophenyl)diazen-1-yl]phenol
- Test material form:
- other: dark red-brown liquid
- Details on test material:
- - Name of test material (as cited in study report): Mortrace SB Conc.
- Physical state: dark red-brown liquid
- Analytical purity: concentrate
- Lot/batch No.: MR 26592 SBC
- Expiry date: June 03, 1993
- Stability under storage conditions: stable
- Stability in vehicle: stability in corn oil not indicated by the sponsor
- Storage condition of test material: at room temperature protected from light
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd., basel, Switzerland
- Age at study initiation: approximately 8 weeks
- Housing: individually housed
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days before start of treatment
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21°C
- Humidity (%): 55%
- Air changes (per hr): 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours light/dark cycle
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- corn oil
- Details on dermal exposure:
- TEST SITE - The formulation was applied to an area of approximately 25 cm2 (5x5 cm) for males and 18 cm2 (3.5x5 cm) for females by application on a gauze patch fixed successively to aluminium foil and flexible bandage (Coban, 3M, St. Paul, U.S.A.), with drops of petrolatum.
REMOVAL OF TEST SUBSTANCE - 24 hours, after exposure residual test substance was removed with a tissue moistened with tap-water.
DOSE LEVEL - 2000 mg/kg body weight
DOSE VOLUME - 10 ml/kg body weight
VEHICLE - corn oil (specific gravity - 0.92)
TEST MATERIAL TREATMENT AND PREPARATION - In order to melt the test substance completely, it was placed for 3 days in a waterbath at 60°C. Chemical analysis (HPLC) of the test substance after melting revealed that the test substance is stable for 3 days at 60°C.
The formulation was prepared immediately prior to dosing. The test substance was heated to maximally 60°C and subsequently weighed into a glass flask on an analytical balance and the vehicle (w/w) was added. The test substance formulation was heated to maximally 60°C to mix the test material. Adjustment was made for specific gravity of vehicle.
Homogeneity of the test substance in vehicle was obtained by using a spatula and by stirring. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 5 males + 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14
- Frequency of observations and weighing: Animals were observed for mortality twice daily and for clinical signs at periodic intervals on the day of application (day 1) and once daily therafter along with the time of onset and duration. Body weights were recorded on days 1 (pre-administration), 8 and 15
- Necropsy of survivors performed: yes - Statistics:
- Standard statistical methods were employed
Results and discussion
- Preliminary study:
- not applicable
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred during the study period
- Clinical signs:
- other: No signs of ill health or behavioural changes were noted in the animals
- Gross pathology:
- Macroscopic post mortem examination of the surviving animals at termination revealed scab formation in one male.
Yellow/orange appearance of the dorsal and abdominal skin, as noted in all animals, can be attributed to staining properties of the test substance. Therefore, this finding was considered to be of no toxicological significance.
Renal pelvic dilation was noted in one female. As this finding is commonly noted among rats of this age and strain, it was considered not to have arisen as a result of treatment. - Other findings:
- Erythema of the treated skin area was noted in one male on days 13 to 15, and scabs were observed in one male and one female during the second week of observation.
The dorsal and abdominal skin was stained yellow/orange by the test substance in all animals from day 2 onwards. No toxicological significance was attached to this finding.
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the study, the dermal LD50 value of MORTRACE SB CONC. in rats of either sex was established as exceeding 2000 mg/kg body weight.
- Executive summary:
The purpose of this study was to assess the toxicity of MORTRACE SB CONC. when administered to rats as a single dermal dose. The study was carried out in accordance with OECD Guideline No. 402, “Acute Dermal Toxicity” and EEC Directive 84/449/EEC, Part B.3, “Acute Toxicity — Dermal”. MORTRACE SB CONC. was administered by dermal application, to five rats of each sex, at 2000 mg/kg body weight. Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed at the end of the experimental period. No animals died during the study. There were no clinical signs of toxicity or behavioural changes noted over the study period. Low body weight gain was noted among the majority of animals over the first week of the observation period. During week 2 of the study, body weight gain by all animals was considered to be similar to that expected of normal untreated animals of the same age and strain. During the second week of the observation period, erythema of the treated skin area was observed in one male, and scabs were noted in one male and one female. Macroscopic post mortem examination of the surviving animals at termination revealed scabs in one male. In the remaining animals, no abnormalities were noted that were not commonly noted among rats of this age and strain or that were considered toxicologically significant. The dermal LD50 value of MORTRACE SB CONC. in rats of either sex was established as exceeding 2000 mg/kg body weight. Based on these results and according to the EEC criteria for classification and labelling requirements for dangerous substances and preparations (EEC Directive 91/325/EEC, Amendment to Annex VI of the EEC Directive 67/548/EEC), M0RTRACE SB CONC. cannot be classified and has no obligatory labelling requirement.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.